Linking Pathogenesis with Disease Modification: Revision vs Reconstruction
Challenge: How can disease modification in Parkinson’s disease become a reality in the near future? If Parkinson’s disease is not a single, homogeneous disorder, can advances in biomarkers and disease modification be revised to concentrate on commonalities of pathogenic mechanisms in large populations OR do they need to be reconstructed for application to smaller subgroups of patients, distinguished by well-defined molecular characteristics?
Steering Committee: Anthony E. Lang, Alfonso Fasano, Francesca Morgante, Alberto J. Espay, Andres M. Lozano, Lorraine Kalia, & Antonio Strafella
For more information and to register for the event, click here.